FAFTFSNP
ALNY icon

Fjarde AP-fonden (The Fourth Swedish National Pensionfund)’s Alnylam Pharmaceuticals ALNY Stock Holding History

Fjarde AP-fonden (The Fourth Swedish National Pensionfund)’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$6.91M Buy
+28,415
New +$4.49M 0.08% 238

Other funds holding ALNY

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fjarde AP-fonden (The Fourth Swedish National Pensionfund)'s ALNY Position: Q2 2024 in Review

Fjarde AP-fonden (The Fourth Swedish National Pensionfund) opened a new position in Alnylam Pharmaceuticals (ALNY) in Q2 2024: 28,415 shares worth $6.91M. The stake represents 0.08% of the portfolio and ranks #238 among its holdings.

522 funds tracked by Wall St. Rank hold ALNY as of Q2 2024.

  • Fjarde AP-fonden (The Fourth Swedish National Pensionfund) held 28,415 shares of Alnylam Pharmaceuticals worth $6.91M as of Q2 2024.
  • Alnylam Pharmaceuticals was a new Fjarde AP-fonden (The Fourth Swedish National Pensionfund) position in Q2 2024.
  • Alnylam Pharmaceuticals made up 0.08% of Fjarde AP-fonden (The Fourth Swedish National Pensionfund)'s portfolio in Q2 2024, its #238 holding.
  • 522 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2024.

Based on Fjarde AP-fonden (The Fourth Swedish National Pensionfund)'s 13F filing for Q2 2024, filed 2 Aug 2024.